

Empowering New Zealand Nurses for Excellence in Healthcare
Bicultural Structure
Membership includes belonging to a bicultural organisation focused on professional nursing issues and community health.
Insurance Coverage
Members receive up to $1 million indemnity insurance in New Zealand (not applicable for retired members). (Conditions apply).
Access to Publications
Members have access to the ‘Nursing Praxis in Aotearoa New Zealand’ journal.
Influence and Networking
Members contribute to a significant influencer in health policy decision-making and join a dynamic network of professional nurses committed to high standards of practice.
1 December 2025
Proposal to widen access to bortezomib for Waldenström’s macroglobulinemia
We want your feedback on a proposal to widen access to bortezomib for people with Waldenström’s macroglobulinemia (WM), a rare type of non-Hodgkin lymphoma. Pharmac included bortezomib in the 2024/25 invitation to tender, and as a result of a price reduction, Pharmac is now proposing to widen access to bortezomib from 1 February 2026. If approved, this would allow people with Waldenström’s macroglobulinemia to receive bortezomib as an initial treatment or following treatment with other funded...
1 December 2025
Amendment to the 2025/26 Invitation to Tender – 01 December 2025
Pharmac has amended the 2025/26 Invitation to Tender with the following updates: Added: thiamine hydrochloride inj 100 mg per ml, 1 ml Amended: bupivacaine hydrochloride with adrenaline inj 0.25% with 1:400,000 of adrenaline, 20 ml non-sterile pack → bupivacaine hydrochloride with adrenaline inj 0.25% with 1:400,000 of adrenaline, 20 ml bupivacaine hydrochloride with adrenaline inj 0.5% with 1:200,000 of adrenaline, 20 ml non-sterile pack → bupivacaine hydrochloride with adrenaline inj...
1 December 2025
Pharmac Update: Primary Care Prescribers | 28 November 2025
Below is the latest information on Pharmac consultations, notifications, and supply issues for Primary Care Prescribers for week 28 November 2025. It includes information on: New updates Resolved Supply Issues Pharmac funding both Estradot and Estradiol TDP Mylan brands of oestradiol patches From 1 December 2025, the funded brands of oestradiol patches will be Estradiol TDP Mylan and Estradot. Everyone who uses funded oestradiol patches will need to use either of these brands. The following...
1 December 2025
Ministry of Health - Medicinal Cannabis Agency
The Misuse of Drugs (Medicinal Cannabis) Regulations 2019 (the Regulations) set the minimum quality standard that medicinal cannabis products and ingredients must meet before they can be supplied in New Zealand. Importers, manufacturers, and suppliers must apply for assessment and provide evidence to the Medicinal Cannabis Agency to verify that their products meet the minimum quality standard. FlorX Full Spectrum CBD120 30 mL has been verified as meeting the minimum quality standard. More...
1 December 2025
Discontinuation: amiloride hydrochloride 5 mg with furosemide 40 mg (Frumil tabs)
Discontinuation: We are writing to inform you of a discontinuation: amiloride hydrochloride 5 mg with furosemide 40 mg (Frumil tabs) Key messages: It is estimated that Frumil stock will run out by the end of February 2026 Please consider prescribing a funded, Medsafe registered, suitable alternative for affected patients. Amiloride 5mg tablets are not Medsafe approved and will need to be prescribed and dispensed in line with Section 29 of the Medicines Act. Our webpage includes a...
1 December 2025
Pharmac consultation: Improving access to treatments in the community for trauma and medical emergencies, and ketamine for palliative care
Please follow this link to the Pharmac consultation regarding improving access to treatments in the community for trauma and medical emergencies, and ketamine for palliative care. We want to make sure that everyone who needs to know about this proposal is aware of it. Please share this information with people you think might be interested. Ngā mihi Pharmac | Te Pātaka Whaioranga | P: +0800 660 050| www.pharmac.govt.nz
30 November 2025
New medicine supply notices
Flumetasone pivalate (Locorten-Vioform) ear drops (Pharmacode 259799) There may be some constrained supply as stock levels get low before the next shipment is released. But more stock should be available soon. FreeStyle Libre 3 Plus sensors: Recall (Pharmacode: 2691655) There is a recall affecting some batches of the FreeStyle Libre 3 Plus sensors. Levonorgestrel: The funded brand is changing (Pharmacode: 2645424) The brand for the emergency contraceptive pill is changing. Details and...
27 November 2025
Tender results
Kia ora, Please follow this link to our website for the November 2025 Tender Notification. Ngā mihi, Stefanie Moir | Tender Analyst Te Pātaka Whaioranga | Pharmac | PO Box 10 254 | Level 9, 40 Mercer Street, Wellington | P: 0800 660 050 | www.pharmac.govt.nz
27 November 2025
Pharmac decision to make HIV medicine access easier
From 1 March 2026 all HIV medicines will be able to be dispensed in three-month amounts, rather than monthly, making it easier for people to manage their treatment. In October, we consulted on three changes to the way New Zealanders access HIV medicines. Thank you to all those who provided feedback. In response to this feedback, we have delayed the proposed effective date from 1 December 2025 to 1 March 2026 to give everyone more time to adapt. We also decided not to remove Special...
27 November 2025
Ministry of Health - Health Improvement & Innovation Digest
Issue 334 - 27 November 2025 Welcome to the fortnightly Health Improvement and Innovation Digest. The Digest has links to key evidence of interest, with access to new content arranged by topic. You can forward this newsletter to others who may be interested in receiving it. They can register and subscribe here . You can also access other recent issues of the digest here. If you have any queries, please email us at library@health.govt.nz Article Access For articles that aren't open access,...
27 November 2025
Copy of RN - to support the development of New Zealand nursing procedures
Looking for a new challenge? We are seeking a passionate Registered Nurse to support the development of New Zealand nursing procedures. Lippincott is offering a part-time, work-from-home, flexible, freelance clinical editor role. Please see job description attached.
26 November 2025
Supply issue: isoniazid 100mg with rifampicin 150mg (Rifinah) Tab
We are writing to inform you that Sanofi, the supplier of isoniazid 100mg with rifampicin 150mg ( Rifinah ) tab, has advised of a supply issue due to delays with manufacturing. The current stock has the expiry date 30 November 2025. Key messages: An alternative brand Rifamazid has been listed (funded) from 1 December 2025. This is an unapproved medicine and as such needs to be prescribed and dispensed in line with section 29 of the Medicines Act. It is estimated it will be available to...
26 November 2025
Proposal to fund nitisinone for people with rare inherited metabolic disorders
We want your feedback on a proposal to fund nitisinone for people with rare inherited metabolic disorders, including tyrosinemia type 1 and alkaptonuria. Nitisinone is currently funded through Pharmac’s Named Patient Pharmaceutical Assessment (NPPA) pathway. Under this proposal, it would be listed on the Pharmaceutical Schedule, making it easier for clinicians to prescribe and helping ensure ongoing supply in New Zealand. More information about the proposal is available here The consultation...
25 November 2025
Goodfellow Unit - Continuing Professional Development
Coming up in CPD: Tricky question... What do Ralph Stewart, Samantha Newman, Ben Chan, Hannah Giles, Ryan Paul, Buzz Burrell (and about 60 others) all have in common? Here's the answer Post-partum hypertension; practical management WEBINAR 2 December: Dr Jamie Kitt, dual accredited Cardiology & General Internal Medicine Consultant on how to achieve optimal blood pressure control in women puerperium. Register here Cannabis-based products The March Medicines Amendment Act aims to enable...
25 November 2025
Nurse Team Leader – Waiheke Island
About the role This full-time (32-40 hours/week) Nurse Team Leader position at Ostend Medical Centre, part of the Waiheke Health Trust, offers the chance to lead a team of primary care nurses providing high-quality care to residents and visitors on beautiful Waiheke Island. As the Nurse Team Leader, you will play a key strategic role in overseeing the nursing team and ensuring the delivery of exceptional patient outcomes. What you'll be doing Provide clinical leadership and direction to the...
25 November 2025
Nurse Practitioner - Waiheke Island
About the role Ostend Medical Centre, part of the Waiheke Health Trust, is seeking an experienced Nurse Practitioner to join our dynamic team on the idyllic Waiheke Island, Auckland. As a Nurse Practitioner, you will play a crucial role in providing comprehensive and compassionate healthcare to our local community. This flexible role (24-40 hours per week) offers the opportunity to work in a supportive and collaborative interdisciplinary environment, delivering a wide range of primary care...
25 November 2025
Proposal to enter into agreement for a range of medical devices supplied by Steris New Zealand Limited
This link will take you to the proposal to enter into an agreement for sterilisation and decontamination equipment and associated consumable medical devices supplied by Steris New Zealand Limited (“Steris”). Steris’ range of medical devices are proposed to be listed on the Pharmaceutical Schedule under a Pharmac agreement from 1 February 2025. A list of products included in the proposal is attached . Pharmac welcomes feedback on this proposal. To provide feedback, please submit it in...
24 November 2025
Pharmac Update: Primary Care Prescribers | 21 November 2025
Below is the latest information on Pharmac consultations, notifications, and supply issues for Primary Care Prescribers for week 21 November 2025. It includes information on: New updates Resolved Supply Issues Pharmac funding both Estradot and Estradiol TDP Mylan brands of oestradiol patches From 1 December 2025, the funded brands of oestradiol patches will be Estradiol TDP Mylan and Estradot. Everyone who uses funded oestradiol patches will need to use either of these brands. The following...
23 November 2025
Pharmac - Supply Update
New medicine supply notices Enalapril: Your brand is changing The funded brand of enalapril is changing from Acetec to Ipca-Enalapril. It will be listed from 1 December 2025. It is the exact same product as supplied under the Ethics brand. Details and a patient flyer available on the website. Oxycodone oral liquid (Lucis) (Pharmacode: 2678500) Following the oxycodone tablet supply issue, there is now limited stock of the oral liquid. An alternative brand, Rosemont (Pharmacode 22717239),...
23 November 2025
Goodfellow Symposium 2026
Smarter consults, better care: What to expect at the 2026 Symposium Need a fast and simple toolkit for mental health consults? Sophie Ball can help with that. Insomnia: a very common complaint within general practice. Alex Bartle will walk us through medication options and strategies to deliver some behavioural treatments within a short consultation. Prostate cancer care is changing fast. Discover how to lead smarter testing, engage in better conversations, and follow up more effectively. And...

